Company profile
remynd
- Industry
- Biotechnology
- Employees
- 28
- Headquarters
- Heverlee, Flemish Region
- Founded
- 2002
- LinkedIn followers
- 3,636
- Office locations
- 1
remynd company summary
remynd is a company in the Biotechnology industry, headquartered in Heverlee, Flemish Region, founded in 2002. On LinkedIn the company has around 28 employees and 3,636 followers. Its listed specialties include protein misfolding diseases, diabetes, Alzheimer's disease, Parkinson's disease, transgenic Alzheimer models.
What technology does remynd use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About remynd
Remynd is a clinical-stage biotechnology company dedicated to developing first-in-class oral therapeutics for neurodegenerative diseases, including Alzheimer’s disease and Huntington’s disease. By targeting the underlying disease mechanisms, reMYND aims to restore neuronal function and slow disease progression. With a strong commitment to innovation and patient impact, the company advances breakthrough therapies from discovery to clinical development.
Specialties
Where is remynd located?
remynd lists 1 location.
Compare companies similar to remynd
More companies in Biotechnology.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
remynd remynd.com | Biotechnology | 28 | 2002 | Heverlee, Flemish Region |
 Regeneron regeneron.com | Biotechnology | 17,234 | - | Tarrytown, New York |
 Bharat Biotech bharatbiotech.com | Biotechnology | 2,035 | 1996 | Hyderabad, Telangana |
 Enzene Biosciences Ltd enzene.com | Biotechnology | 1,023 | 2008 | Pune, Maharashtra |
| Biotechnology | 393 | - | Bethesda, MD | |
 LifeCell International Pvt.Ltd lifecell.in | Biotechnology | 2,650 | 2004 | Chennai, India |
 TMG - Tropical Melhoramento & Genética tmg.agr.br | Biotechnology | 692 | 2001 | Cambé, PR |
 Organica Biotech organicabiotech.com | Biotechnology | 146 | 2000 | Mumbai, Maharashtra |
 Allogene Therapeutics allogene.com | Biotechnology | 217 | 2017 | South San Francisco, California |
 Labtest Diagnóstica S.A. labtest.com.br | Biotechnology | 227 | 1971 | Lagoa Santa, Minas Gerais |
 Orchard Therapeutics - U.S. orchard-tx.com | Biotechnology | 243 | 2015 | London, United Kingdom |
Frequently asked questions about remynd
What does remynd do?
Remynd is a clinical-stage biotechnology company dedicated to developing first-in-class oral therapeutics for neurodegenerative diseases, including Alzheimer’s disease and Huntington’s disease. By targeting the underlying disease mechanisms, reMYND aims to restore neuronal function and slow disease progression. With a strong commitment to innovation and patient impact, the company advances breakthrough therapies from discovery to clinical development.
How many employees does remynd have?
remynd has around 28 employees on LinkedIn.
Where is remynd headquartered?
remynd is headquartered in Heverlee, Flemish Region.
When was remynd founded?
remynd was founded in 2002.
Build a lead list from companies like remynd
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.